Emergency departments in state of emergency: report
11 November, 2022A new report by the ACEM has found that EDs across Australia saw the highest number of patient presentations ever recorded in 2020–21.
Surgeon expresses concern over delayed scoliosis treatment
04 November, 2022An Epworth spinal surgeon is concerned cases of curvature of the spine known as scoliosis may have been missed in teenagers throughout the pandemic.
Is America's opioid epidemic Australia's future?
31 August, 2022Overdose has taken the lives of over 35,000 Australians since 2001. It is a leading cause of death for all ages and sexes, second only to suicide for those in their 30s.
New allergy initiatives to accelerate research, clinical care
31 August, 2022Two new health organisations aim to improve the lives of five million Australians living with allergies and prevent anaphylaxis, including needless deaths.
AI model to predict anti-seizure medication
31 August, 2022Choosing anti-seizure drugs for a patient is a process of trial and error with clinicians unable to predict which drug a particular patient will respond to.
NSW, Vic team up to set up urgent care centres
30 August, 2022The states will establish these centres in partnership with general practitioners (GPs) bringing the total number of services across both states to 50.
ED admissions spike after bushfires
25 July, 2022New research is said to have found a direct link between people's exposure to bushfire smoke and visits to Perth's emergency departments.
Ambulance ramping linked to 30-day death risk, re-attendance
04 July, 2022Victorian research published in the MJA reveals that longer ambulance offload times are linked to greater 30-day risks of death and ambulance re-attendance.
Writing an asthma action plan
08 June, 2022 by Professor Nick Zwar, Executive Dean of the Faculty of Health Sciences & Medicine, Bond University and Chair of the National Asthma Council Guidelines CommitteeHealth professionals as well as governments are anxious about this year's flu season, and case numbers are already climbing.
LivaNova receives TGA approval for VNS therapy system
07 December, 2021LivaNova has received TGA approval for SenTiva for the treatment of patients with drug-resistant epilepsy (DRE) using vagus nerve stimulation (VNS) therapy.
Anaphylaxis: ED visits up by 51%, new care standard released
24 November, 2021The Australian Commission on Safety and Quality in Health Care (the Commission) has released the first national standard of care for patients with anaphylaxis.
Contaminated venous tourniquets: is there a better solution for infection control?
01 October, 2021Tourniquets are classified as 'non-critical' medical devices and are one of the most widely used pieces of medical equipment across a number of settings.
How to avoid dangerous mistakes when responding to anaphylaxis
18 June, 2021World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.
Personal defibrillator gains CE certification
01 June, 2021Sydney-based medical device start-up RRR has secured European regulatory approval for its personal automated external defibrillator (AED), CellAED.
New adrenaline autoinjectors give choice to Australians with allergies
12 April, 2021The approval means that Australians weighing 60 kg and over living with anaphylaxis can now access a 500 mcg adrenaline autoinjector dose.
